A Prospective, Single-center, Blinded, Randomized, Split-face Study Evaluating the Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides
Ten subjects will be enrolled in the study. Each subject will have their left and right forehead randomly assigned to receive 4 units of PrabotulinumtoxinA-xvfs or OnabotulinumtoxinA. Subjects will be reassessed at 2 weeks for evaluation of rhytide diminution around each injection point to assess relative diffusion of each drug in the forehead.
100 项与 Lupo Center for Aesthetic and General Dermatology 相关的临床结果
0 项与 Lupo Center for Aesthetic and General Dermatology 相关的专利(医药)
100 项与 Lupo Center for Aesthetic and General Dermatology 相关的药物交易
100 项与 Lupo Center for Aesthetic and General Dermatology 相关的转化医学